Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAGLN2 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
mRNA | DAB2IP | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | GPR27 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
mRNA | TBP | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | PCBP1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
mRNA | CERS2 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
mRNA | EXOSC2 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
mRNA | NIF3L1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
mRNA | DEFA4 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
mRNA | STYX | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |